Powered by

FDA's second-in-command Abernethy leaving agency as Biden's commissioner yet to be named

Mar 24, 2021 - FiercePharma

The FDA's second-in-command and acting chief information officer, Amy Abernethy, is leaving the agency next month. Her unexpected departure comes as the search for a permanent FDA Commissioner under the Biden administration continues. Abernethy was considered as acontender for the job earlierin the process.

After justtwo years at the FDA, principal deputy chief Amy Abernethy is leaving the agency. As second-in-command and acting chief information officer, Abernethy oversawtech and data mod...